Mesorectal lymph node involvement and prognostic implications at total pelvic exenteration for gynecologic malignancies.

MLA

Mourton, Susannah M., et al. “Mesorectal Lymph Node Involvement and Prognostic Implications at Total Pelvic Exenteration for Gynecologic Malignancies.” Gynecologic Oncology, vol. 100, no. 3, Mar. 2006, pp. 533–36. EBSCOhost, https://doi.org/10.1016/j.ygyno.2005.08.039.

APA

Mourton, S. M., Chi, D. S., Sonoda, Y., Alektiar, K. M., Venkatraman, E. S., Barakat, R. R., & Abu-Rustum, N. R. (2006). Mesorectal lymph node involvement and prognostic implications at total pelvic exenteration for gynecologic malignancies. Gynecologic Oncology, 100(3), 533–536. https://doi.org/10.1016/j.ygyno.2005.08.039

Chicago

Mourton, Susannah M, Dennis S Chi, Yukio Sonoda, Kaled M Alektiar, Ennapadam S Venkatraman, Richard R Barakat, and Nadeem R Abu-Rustum. 2006. “Mesorectal Lymph Node Involvement and Prognostic Implications at Total Pelvic Exenteration for Gynecologic Malignancies.” Gynecologic Oncology 100 (3): 533–36. doi:10.1016/j.ygyno.2005.08.039.